The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| 10X GENOMICS INC | CL A COM | 88025U109 | 48,298,250 | 2,275,000 | SH | SOLE | 2,275,000 | 0 | 0 | |||
| ABSCI CORPORATION | COM | 00091E109 | 2,919,780 | 973,260 | SH | SOLE | 973,260 | 0 | 0 | |||
| ADLAI NORTYE LTD | SPONSORED ADS | 00704R109 | 3,726,150 | 538,461 | SH | SOLE | 538,461 | 0 | 0 | |||
| AGOMAB THERAPEUTICS NV | SPONSORED ADS | 00860C102 | 16,259,500 | 1,550,000 | SH | SOLE | 1,550,000 | 0 | 0 | |||
| ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 24,815,250 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | |||
| BEAM THERAPEUTICS INC | COM | 07373V105 | 32,170,500 | 1,350,000 | SH | SOLE | 1,350,000 | 0 | 0 | |||
| BIOLIFE SOLUTIONS INC | COM NEW | 09062W204 | 113,662,708 | 5,957,165 | SH | SOLE | 5,957,165 | 0 | 0 | |||
| BRIDGEBIO ONCOLOGY THERAPEUT | COM NEW | 107924102 | 2,526,692 | 282,312 | SH | SOLE | 282,312 | 0 | 0 | |||
| CENTURY THERAPEUTICS INC | COM | 15673T100 | 2,775,709 | 1,228,190 | SH | SOLE | 1,228,190 | 0 | 0 | |||
| CONTINEUM THERAPEUTICS INC | CL A | 21217B100 | 1,937,229 | 148,333 | SH | SOLE | 148,333 | 0 | 0 | |||
| DENALI THERAPEUTICS INC | COM | 24823R105 | 35,328,000 | 1,840,000 | SH | SOLE | 1,840,000 | 0 | 0 | |||
| DISC MEDICINE INC | COM | 254604101 | 4,156,100 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | |||
| GENEDX HOLDINGS CORP | COM CL A | 81663L200 | 193,120,072 | 3,007,164 | SH | SOLE | 3,007,164 | 0 | 0 | |||
| GINKGO BIOWORKS HOLDINGS INC | CL A NEW | 37611X209 | 223,702 | 36,493 | SH | SOLE | 36,493 | 0 | 0 | |||
| GRAIL INC | COM | 384747101 | 11,886,400 | 230,000 | SH | SOLE | 230,000 | 0 | 0 | |||
| GUARDANT HEALTH INC | COM | 40131M109 | 29,096,550 | 315,000 | SH | SOLE | 315,000 | 0 | 0 | |||
| HIMS & HERS HEALTH INC | COM CL A | 433000106 | 14,532,000 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | |||
| ILLUMINA INC | COM | 452327109 | 65,327,800 | 530,000 | SH | SOLE | 530,000 | 0 | 0 | |||
| INTELLIA THERAPEUTICS INC | COM | 45826J105 | 4,551,100 | 355,000 | SH | SOLE | 355,000 | 0 | 0 | |||
| MAZE THERAPEUTICS INC | COM | 578784100 | 22,651,881 | 758,857 | SH | SOLE | 758,857 | 0 | 0 | |||
| MODERNA INC | COM | 60770K107 | 3,810,000 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | |||
| MONTE ROSA THERAPEUTICS INC | COM | 61225M102 | 3,059,930 | 186,014 | SH | SOLE | 186,014 | 0 | 0 | |||
| MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | 8,388,000 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | |||
| NEUROGENE INC | COM | 64135M105 | 28,634,478 | 1,420,361 | SH | SOLE | 1,420,361 | 0 | 0 | |||
| PACIFIC BIOSCIENCES CALIF IN | COM | 69404D108 | 955,372 | 723,767 | SH | SOLE | 723,767 | 0 | 0 | |||
| PERSONALIS INC | COM | 71535D106 | 10,192,000 | 1,600,000 | SH | SOLE | 1,600,000 | 0 | 0 | |||
| PRIME MEDICINE INC | COM | 74168J101 | 11,021,769 | 3,167,175 | SH | SOLE | 3,167,175 | 0 | 0 | |||
| QIAGEN NV | ORD SHARES | N72482156 | 14,414,400 | 360,000 | SH | SOLE | 360,000 | 0 | 0 | |||
| QUEST DIAGNOSTICS INC | COM | 74834L100 | 9,799,000 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | |||
| RECURSION PHARMACEUTICALS IN | CL A | 75629V104 | 507,542 | 165,323 | SH | SOLE | 165,323 | 0 | 0 | |||
| RELAY THERAPEUTICS INC | COM | 75943R102 | 143,464,811 | 14,418,574 | SH | SOLE | 14,418,574 | 0 | 0 | |||
| REVOLUTION MEDICINES INC | COM | 76155X100 | 250,645,634 | 2,577,333 | SH | SOLE | 2,577,333 | 0 | 0 | |||
| SCHOLAR ROCK HLDG CORP | COM | 80706P103 | 17,206,000 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | |||
| SEPTERNA INC | COM | 81734D104 | 13,295,030 | 553,268 | SH | SOLE | 553,268 | 0 | 0 | |||
| STANDARD BIOTOOLS INC | COM | 34385P108 | 81,618,999 | 88,783,856 | SH | SOLE | 88,783,856 | 0 | 0 | |||
| STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 86366E106 | 56,635,000 | 1,175,000 | SH | SOLE | 1,175,000 | 0 | 0 | |||
| TAYSHA GENE THERAPIES INC | COM SHS | 877619106 | 14,527,500 | 3,250,000 | SH | SOLE | 3,250,000 | 0 | 0 | |||
| TEMPUS AI INC | CL A | 88023B103 | 13,300,423 | 294,127 | SH | SOLE | 294,127 | 0 | 0 | |||
| TENAYA THERAPEUTICS INC | COM | 87990A106 | 250,627 | 361,969 | SH | SOLE | 361,969 | 0 | 0 | |||
| VERACYTE INC | COM | 92337F107 | 8,899,881 | 276,308 | SH | SOLE | 276,308 | 0 | 0 | |||